Catalyst MedTech Unveils Propel Partner Program to Transform Diagnostic Imaging Landscape
Catalyst MedTech, a prominent figure in the realm of nuclear medicine and molecular imaging, launched its Propel Partner Program, signaling a significant step towards revolutionizing the operational landscape for Original Equipment Manufacturers (OEMs) in diagnostic imaging. This initiative, which aims to accelerate innovation and foster growth within the industry, was officially unveiled on June 17, 2025.
The Propel Partner Program is more than just a service contract; it serves as a comprehensive partnership platform designed to equip forward-thinking OEMs with the customized support they need to thrive in the United States. By providing a framework that encompasses an array of services, Catalyst MedTech ensures that these partners have access to crucial infrastructure vital for their operational success. The program includes extensive customer service dispatch, expert field service, system installation, clinical applications training, and efficient parts logistics, along with access to Catalyst’s proprietary operations and inventory platform.
As noted by Martin Shirley, President and CEO of Catalyst MedTech, the Propel Program embodies the company’s commitment to collaboration. "This program puts our collaboration value into motion," he stated, emphasizing that Propel is tailored for innovative technology developers seeking immediate operational support. "We’re not here to do what’s always been done — we’re here to help the industry move forward, partner by partner."
Catalyst MedTech has already begun forming strategic alliances, including a partnership with Epica International, which recently became the third official Propel Partner. Epica International, known for its advancements in CT imaging applications within both veterinary and human medicine, has opted for Catalyst MedTech’s services to elevate its operational capabilities in the competitive U.S. market. Omar Oliveros, U.S. Director of Service and Support at Epica International, praised the collaboration, highlighting the outstanding service and professionalism exhibited by the Catalyst team.
This partnership is significant not only for Epica but for the broader industry as well. It enables Epica to effectively manage its over 400 domestic installations while providing scalable service solutions aligned with future market growth. Shirley expressed pride in welcoming Epica to the Propel Partner community, acknowledging the company’s dedication to advancing CT imaging technology. Catalyst MedTech aims to ensure that such partners receive the exemplary support that parallels the innovative solutions they provide.
The Propel Partner Program positions Catalyst MedTech as the only independent, ISO-certified service provider in the sector, offering essential multi-vendor support across nuclear medicine, molecular imaging, and CT systems. This unique advantage allows them to help Propel Partners navigate and overcome contemporary industry challenges, particularly by delivering a nationwide infrastructure that guarantees customer success and facilitates the market penetration of essential diagnostic technologies.
Key benefits of the Propel partnership include nationwide field service coverage, logistics for critical parts storage and distribution, robust customer case management, a real-time operational dashboard, and expert clinical and technical consulting for systems and protocols.
Open to OEMs at every developmental stage, from ambitious startups to established entities, the Propel Partner Program is set to expand further throughout 2025 with additional partners joining the initiative. As the industry gears up for SNMMI 2025 in New Orleans, Catalyst MedTech invites attendees to Booth #701 to discover the potential for collaboration and innovation.
With a mission to enable healthcare providers across the U.S. to 'See What's Possible' through cutting-edge nuclear medicine, molecular imaging, and CT solutions, Catalyst MedTech continues to position itself as a leader in the healthcare technology landscape. For more details, visit their website at www.catalystmedtech.com.